Gentis news

Eurofins GENTIS Welcomes CAP Expert Delegation: Strengthening Professional Connections, Affirming Commitment to International Quality

Created date : 05-08-2026
Updated date: 05-08-2026
Author: Eurofins Gentis
On August 4th, Eurofins GENTIS was honored to welcome a delegation of experts from the College of American Pathologists (CAP) for a visit and professional exchange at its laboratory system. This event was a crucial opportunity for Eurofins GENTIS, along with international experts and partners in the field of laboratory quality management, to share experiences, update professional standards, and further promote the values ​​of quality, accuracy, and safety in genetic testing.
Main content

Attending the program were Ms. Warinthorn Thanathananon - International Regional Technical Advisor from the College of American Pathologists (CAP); representatives from LAQAS Joint Stock Company - the representative and distributor of CAP in Vietnam; and the leadership and professional team of Eurofins GENTIS.

Opportunities for Professional Exchange According to International Standards


During the working session, the CAP expert delegation visited Eurofins GENTIS's laboratory system, learning about operational processes, testing capabilities, and ongoing quality management activities.
The discussions focused on key requirements in the field of genetic testing, including testing process management, quality control, system performance evaluation, and training and development of professional staff. This was also an opportunity for both sides to share practical perspectives on maintaining the stability, accuracy, and reliability of test results – factors that play a crucial role in supporting doctors and patients in making appropriate healthcare decisions.
Regular connections with international professional organizations help Eurofins GENTIS not only stay updated on new requirements in the testing industry but also continue to improve its quality management system towards professionalism, transparency, and sustainability.


Milestone: CAP Certification for PGT and NIPT Testing in 2025


In 2025, Eurofins GENTIS achieved CAP certification for two important test groups: PGT (Preimplantation Genetic Testing) and NIPT (Non-Invasive Prenatal Testing).

CAP is one of the world's leading reputable organizations in the field of pathology and laboratory quality management. CAP certification is considered an important international standard, comprehensively assessing the professional competence, operational processes, and quality assurance systems of laboratories.

To achieve this certification, laboratories need to meet stringent requirements related to many aspects, from personnel competence, equipment, technical procedures to continuous quality control and improvement systems.

Eurofins GENTIS's achievement of CAP certification for PGT and NIPT is proof of its serious investment in building an internationally standardized testing system, and demonstrates its commitment to providing highly accurate, reliable, and safe genetic testing services.
Maintaining quality standards in every testing process
Beyond aiming for international certifications, Eurofins GENTIS always focuses on maintaining and continuously improving its quality system to meet the stringent requirements of CAP.

One of the key factors is building a team of highly qualified personnel, well-trained and regularly updating their knowledge in the field of genetics. The team of experts and technicians at Eurofins GENTIS always adhere to strict professional procedures at every stage of the testing process.

In addition, a comprehensive quality assurance system is implemented, including:

  • Internal quality control to monitor the stability and accuracy of the testing process.
  • Participation in external quality assessment programs to compare testing capabilities with international standards.
  • Strict management of the process of receiving, processing, and storing test samples.
  • Regular evaluation and monitoring of operational steps to promptly identify and improve areas for improvement.
  • Applying modern technology to optimize processes and enhance the reliability of results.

These activities not only help Eurofins GENTIS maintain international quality standards but also contribute to building trust with healthcare partners, doctors, and customers when choosing genetic testing solutions.


Commitment to the Development of Precision Medicine


The event of welcoming the CAP expert delegation further affirms Eurofins GENTIS's development direction in improving the quality of testing and integrating with global medical standards.
In the future, Eurofins GENTIS will continue to maintain cooperation with international professional organizations, constantly update technology, enhance the capacity of its team, and perfect its quality management system. This is an important foundation for Eurofins GENTIS to continue providing advanced genetic testing solutions, contributing effectively to supporting the development of the field.

Đánh giá bài viết
0.0/5  –  0 lượt đánh giá

Để lại bình luận

0 Bình luận

Có thể bạn quan tâm

ĐĂNG KÝ DỊCH VỤ TẠI GENTIS

Cảm ơn Quý khách đã tin tưởng sử dụng dịch vụ của GENTIS,
Quý khách vui lòng điền thông tin bên dưới để được hỗ trợ,
tư vấn một cách tốt nhất!